entertainment -WSS

entertainment

author：focus 2025-10-01 14:59:22 - browse：674

A handout illustration representing Google’s DeepMind subsidiary and Isomorphic Labs developed an AI model that can accurately predict how a vast universe of biomolecules interact on an atomic level. — DeepMind

Google on Wednesday unveiled an artificial intelligence tool capable of predicting the structure and interaction of a vast universe of biomolecules, a fundamental advance that may help scientists unravel poorly understood aspects of biology and disease.

The new AI, dubbed AlphaFold 3, improves upon earlier versions of the model by predicting not just the structure of proteins, but all the molecules that interact with them in cells, including RNA, DNA, ions, and other small molecules.

Most new drugs consist of small molecules designed to bind to a protein involved in disease. AlphaFold 3 opens broader avenues of exploration, allowing scientists to rapidly examine complex interactions with other molecules that may highlight new disease targets — and different ways of attacking them.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Guidelines to prevent youth baseball injuries need more muscle
Next article： Amylyx's ALS drug launch starts strong. It could be trouble for FDA

WSS

Wegovy’s successful heart trial raises vital question about weight loss

South Korea throws huge K

American woman, child freed after being kidnapped in Haiti last month

In medicine, common shorthands can shortchange care

Amylyx's ALS drug launch starts strong. It could be trouble for FDA

Moderna hits safety problems in bold bid to reinvent medicine

focus

entertainment

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

hotspot

Jerome Adams on the need for new antivirals for Covid

Illinois to ban advertising for guns allegedly marketed to kids and militants

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Why failed clinical trials don’t always spell doom for a new drug

How to save PrEP access — and even expand it

Tesla CFO Zachary Kirkhorn steps down, but will remain with company through year's end

Alkermes shareholders re

Friends ask where James Watson's attitudes about race came from

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Man killed during FBI raid in connection with threats against Biden, other officials

Wikipedia

Hawaii wildfires fueled by Hurricane Dora's winds prompt evacuations

Man killed during FBI raid in connection with threats against Biden, other officials

Moderna hits safety problems in bold bid to reinvent medicine

A biotech analyst on neuroscience, placebo effect, not over

Bursting ice dam in Alaska highlights risks of glacial flooding around the globe

Israel demolishes home of alleged Palestinian attacker, fueling West Bank tensions

hotspot

hotspot

explore

explore